THEOFAN GEORGIA 4
4 · IMMUNE RESPONSE CORP · Filed Jan 19, 2005
Insider Transaction Report
Form 4
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Award
Common Stock
2004-12-31$1.61/sh+1,902$3,062→ 14,929 total
Footnotes (1)
- [F1]Matching company contribution to 401K account.